Director: Bruce Levine, PhD
The Clinical Cell and Vaccine Production Facility (CVPF) renders bench-to-bedside translational medicine a reality. Equipped with state-of-the-art facilities, the CVPF manufactures cell and gene biotherapeutics and is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) as well as by the College of American Pathologists (CAP). Further, the CVPF is the only GMP (good manufacturing practices) compliant facility on campus and functions as an NCI-approved Abramson Cancer Center Shared Resource. As an ACC Shared Resource and Path and BioResources core facility, the CVPF supports numerous investigational new drug (IND) protocols. Current protocols target a variety of disease indications (primarily HIV, adult and pediatric cancers, and stroke); many more trials are in development and, once approved, will further expand the scope of diseases targeted for cell and gene therapy.
Bruce Levine, PhD
For more information, please visit the Facility’s website: https://somapps.med.upenn.edu/pbr/cvpf/index.html